Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 35c, Revenues Beat; Offers FY20 Revenue Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Akcea Therapeutics to Present at the Cowen 40th Annual Health Care Conference
February 26, 2020 7:01 AM ESTBOSTON, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious and rare diseases, today announced that Damien McDevitt, Interim CEO, will present at the Cowen 40th Annual Health Care Conference in Boston on Tuesday, March 3, 2020 at 10:40 a.m. ET.
The above listed date is subject to change. Details on presentation times or changes to presentation dates can be found on the Companys website. Please check... More
